Global health expenditure is projected to exceed US$10 trillion, while payer margins remain under pressure from medical inflation and cross-border complexity.[1]
For international carriers and TPAs, cost containment in 2026 is no longer a single utilization-management function. It is an integrated operating model across network, clinical governance, claims, payment, pharmacy, and fraud controls.
1) Network Access and Unit-Cost Steering
Directing members into contracted facilities is still the highest-confidence lever for claims control. Strong direct-billing networks reduce leakage and out-of-network inflation exposure.[2][3]
2) Pre-Authorization Governance
Prior authorization remains a meaningful cost-control mechanism when automated and clinically targeted. Milliman estimates removing PA can increase premiums by ~US$20-30 PMPM, with commercial impact of US$43B-US$63B annually.[4]
3) Concurrent Review for Inpatient Episodes
Concurrent review reduces avoidable length-of-stay drift and supports earlier discharge planning, particularly in high-cost medical and surgical lines.[5]
4) Bill Review and Coding Integrity
Systematic bill review identifies duplicate charges, non-covered items, and coding inconsistencies before payment. Claims analytics platforms continue to show significant recoveries from pre-payment controls.[6]
5) UCR Repricing and Out-of-Network Discipline
Out-of-network reimbursement should be tied to transparent usual-and-customary benchmarks by market to limit balance-bill inflation and prevent uncontrolled reimbursement variance.[7]
6) Prompt Pay to Unlock Better Contract Terms
Fast claims payment is not only a service metric; it is a negotiation lever. Programs using rapid digital payout infrastructure report lower admin friction and better provider willingness to participate in direct-pay models.[8][9]
7) Pharmacy Management and Formulary Controls
High-cost specialty and chronic therapies require formularies, prior clinical checks, and therapeutic-substitution pathways. Studies continue to show unmanaged pharmacy spend materially lifts total claim cost trend.[10]
8) Fraud, Waste, and Abuse Detection
Fraud/waste estimates in healthcare commonly range from 3% to 10% of total spend, making FWA controls one of the highest-ROI functions in claims operations.[11] AI-supported anomaly detection and pre-payment edits improve recovery and prevention rates when paired with clinical audit teams.[12]
Execution Checklist for TPAs
- Define top 20 diagnosis-related cost drivers by geography.
- Set monthly leakage, denial overturn, and outlier-payment dashboards.
- Deploy payment-speed KPI tied to network retention.
- Run quarterly FWA model recalibration and provider outlier review.
The Bottom Line
The strongest international cost-containment programs combine eight levers into one operating cadence. Isolated initiatives underperform; integrated execution delivers durable savings and better member outcomes. To benchmark your model, visit MDabroad or contact MDabroad.
References
- WHO. Global Health Expenditure Database. 2025. URL
- APRIL International. Direct Billing and Network Access. 2023. URL
- Mercer. Cost of Living and Mobility Pressures. 2024. URL
- NAIC. Prior Authorization White Paper. 2025. URL
- AMA. Prior Authorization Delays Care and Increases Resource Utilization. 2024. URL
- Council for Affordable Quality Healthcare (CAQH). Index on Administrative Costs. 2024. URL
- KFF. Out-of-Network Billing and Cost Exposure. 2024. URL
- Vitesse. Real-Time Insurance Payouts. 2026. URL
- WEX. Virtual Cards and Claims Payment Delays. 2025. URL
- OECD. Health at a Glance. 2025. URL
- ACFE. What Data Says About Health Care Fraud. 2024. URL
- CMS Innovation Center. Wasteful and Inappropriate Service Reduction (WISeR) Model. 2025. URL